DW

David Matthew Wilson

GL Glaxo Group Limited: 15 patents #44 of 1,368Top 4%
SP Smithkline Beeacham P.L.C.: 7 patents #67 of 690Top 10%
Merck: 2 patents #3,919 of 9,382Top 45%
DI Dana-Farber Cancer Institute: 2 patents #445 of 1,343Top 35%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
GL Glaxosmithkline: 1 patents #290 of 646Top 45%
BL Berlex Laboratories: 1 patents #61 of 98Top 65%
MT Metabasis Therapeutics: 1 patents #48 of 71Top 70%
📍 Stevenage, KS: #1 of 1 inventorsTop 100%
Overall (All Time): #113,139 of 4,157,543Top 3%
32
Patents All Time

Issued Patents All Time

Showing 1–25 of 32 patents

Patent #TitleCo-InventorsDate
10815218 Benzoimidazole derivatives as PAD4 inhibitors Dominique Amans, Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo +7 more 2020-10-27
10653676 Small molecule inhibitors of USP1 deubiquitinating enzyme activity Alan D'Andrea, Gregory D. Cuny, Ross L. Stein, Marcie Glicksman, April Case +2 more 2020-05-19
10407407 Benzoimidazole derivatives as PAD4 inhibitors Dominique Amans, Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo +7 more 2019-09-10
10039755 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo, Clement Douault +5 more 2018-08-07
9833449 2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo, Clement Douault +5 more 2017-12-05
9624219 Compound (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropyrido[3,4-d]pyrimidin-3(4H)-yl)butanamide and use Jose-Miguel Coteron Lopez, Esther Pilar Fernandez Velando, Jorge Fernandez-Molina, Maria Luisa Leon-Diaz 2017-04-18
9518032 Small molecule inhibitors of USP1 deubiquitinating enzyme activity Alan D'Andrea, Gregory D. Cuny, Ross L. Stein, Marcie Glicksman, April Case +2 more 2016-12-13
9518054 2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo, Clement Douault +5 more 2016-12-13
9447074 Compounds Francis Louis Atkinson, Michael David Barker, John Liddle 2016-09-20
9127003 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors Stephen John Atkinson, Michael David Barker, Matthew James Campbell, Hawa Diallo, Clement Douault +5 more 2015-09-08
8993560 Compounds Francis Louis Atkinson, Michael David Barker, John Liddle 2015-03-31
8697725 Tetrahydroquinoline derivatives and their pharmaceutical use Emmanuel Hubert Demont, Neil Stuart Garton, Romain Luc Marie Gosmini, Thomas George Christopher Hayhow, Jonathan Thomas Seal +1 more 2014-04-15
8691747 Method of treatment based on ATAD2 inhibitors Laurens Kruidenier, Kevin J. Lee, David Francis Tough 2014-04-08
8633319 7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors Francis Louis Atkinson, Michael David Barker, Clement Douault, Neil Stuart Garton, John Liddle +2 more 2014-01-21
8410284 Cyclic benzimidazole derivatives useful as anti-diabetic agents Qun Dang, Tony S. Gibson, Hongjian Jiang, De Michael Chung, Jianming Bao +10 more 2013-04-02
8394969 Cyclic benzimidazole derivatives useful as anti-diabetic agents Brett C. Bookser, Qun Dang, Tony S. Gibson, Hongjian Jiang, De Michael Chung +10 more 2013-03-12
8207331 Benzazepine derivatives for the treatment of neurological disorders Mark James Bamford, David Kenneth Dean, Sanjeet Singh Sehmi, Jason Witherington 2012-06-26
7888347 Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists Mark James Bamford 2011-02-15
7799773 Benzazepine derivatives for the treatment of neurological disorders Mark James Bamford, David Kenneth Dean, Sanjeet Singh Sehmi, Jason Witherington 2010-09-21
7704994 Benzazepine derivatives for the treatment of neurological disorders Sanjeet Singh Sehmi, Jason Witherington 2010-04-27
7696193 Benzazepine derivatives for the treatment of neurological disorders Sanjeet Singh Sehmi, Jason Witherington 2010-04-13
7615550 Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists Thomas Daniel Heightman, Simon Teanby Hodgson, Matthew Lindon 2009-11-10
7452906 Pyridine derivatives as Raf kinase inhibitors Mark James Bamford, David Kenneth Dean, Antoinette Naylor, Andrew Kenneth Takle 2008-11-18
7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors David Kenneth Dean, Andrew Kenneth Takle 2008-11-04
7375105 Pyridine substituted furan derivatives as Raf kinase inhibitors David Kenneth Dean, Andrew Kenneth Takle 2008-05-20